Stress Echo 2020 - The International Stress Echo Study
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Pulmonary Arterial Hypertension
Related studies linked through entity extraction aliases.
Impact of Rehabilitation Program on PAH Patients Treated With Macitentan.
- Status
- UNKNOWN
- Phase
- NA
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Symptomatic Adult PAH
- Status
- WITHDRAWN
- Phase
- PHASE2
Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial Hypertension
- Status
- WITHDRAWN
- Phase
- PHASE3
Pulmonary Vascular Disease Phenomics Program PVDOMICS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension (OPTIMA)
- Status
- TERMINATED
- Phase
- PHASE4
The Effect of Adding Exercise Training to Optimal Therapy in PAH
- Status
- COMPLETED
- Phase
- NA
FDG Uptake and Lung Blood Flow in PAH Before and After Treatment With Ambrisentan
- Status
- WITHDRAWN
- Phase
- NA
Long-term Extension Study of the Safety and Pharmacokinetics of QCC374 in PAH Patients
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients
- Status
- TERMINATED
- Phase
- PHASE2
Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE2
[18F]FES PET/CT in PAH
- Status
- TERMINATED
- Phase
- N/A
Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension
- Status
- WITHDRAWN
- Phase
- PHASE4
Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy
- Status
- COMPLETED
- Phase
- PHASE4
LenusPro Pump in PAH Treated With Treprostinil
- Status
- UNKNOWN
- Phase
- N/A
Contribution of Echocardiography to Prognostic Evaluation of Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- N/A
Crossover Study From Macitentan or Bosentan Over to Ambrisentan
- Status
- TERMINATED
- Phase
- PHASE4
An Open Label Extension Study to Evaluate the Safety of Continued Therapy of Subcutanous Remodulin® in Pulmonary Arterial Hypertension
- Status
- WITHDRAWN
- Phase
- PHASE4